Edition:
India

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

1.54USD
30 Sep 2020
Change (% chg)

-- (--)
Prev Close
$1.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
67,852
52-wk High
$4.10
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Clearside Biomedical Q2 Loss Per Share $0.15
Thursday, 8 Aug 2019 

Aug 7 (Reuters) - Clearside Biomedical Inc ::CLEARSIDE BIOMEDICAL ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 LOSS PER SHARE $0.15.Q2 EARNINGS PER SHARE ESTIMATE $-0.39 -- REFINITIV IBES DATA.BELIEVE WILL NOW HAVE SUFFICIENT RESOURCES TO FUND PLANNED OPERATIONS INTO Q3 OF 2020.CASH AND CASH EQUIVALENTS TOTALED $26.2 MILLION AS OF JUNE 30, 2019.  Full Article

Clearside Biomedical Announces License Agreement With Aura Biosciences
Tuesday, 9 Jul 2019 

July 9 (Reuters) - Clearside Biomedical Inc ::CLEARSIDE BIOMEDICAL ANNOUNCES LICENSE AGREEMENT WITH AURA BIOSCIENCES FOR SUPRACHOROIDAL SPACE MICROINJECTOR™ DESIGNED TO OPTIMIZE OCULAR ONCOLOGY DRUG DELIVERY.CLEARSIDE BIOMEDICAL INC - CO ELIGIBLE TO RECEIVE PAYMENTS RELATED TO PRE-SPECIFIED DEVELOPMENT, REGULATORY AND SALES MILESTONES.CLEARSIDE BIOMEDICAL INC - CO IS ELIGIBLE TO RECEIVE ROYALTIES ON PRODUCT SALES THAT UTILIZE SCS MICROINJECTOR.CLEARSIDE BIOMEDICAL INC - IF COLLABORATION PROVES SUCCESSFUL, AURA MAY UTILIZE SCS MICROINJECTOR FOR CERTAIN FUTURE DEVELOPMENT PROGRAMS.  Full Article

Clearside Biomedical Reports Q1 2019 Results
Wednesday, 8 May 2019 

May 8 (Reuters) - Clearside Biomedical Inc ::CLEARSIDE BIOMEDICAL ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q1 LOSS PER SHARE $0.45.Q1 EARNINGS PER SHARE ESTIMATE $-0.40 -- REFINITIV IBES DATA.XIPERE UNDER REVIEW FOR OCTOBER 19, 2019 PDUFA DATE.CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $34.9 MILLION AS OF MARCH 31, 2019.  Full Article

BRIEF-Clearside Biomedical Files For Common Stock Offering Of Upto $50 Mln

* CLEARSIDE BIOMEDICAL INC FILES FOR COMMON STOCK OFFERING OF UPTO $50.0 MILLION - SEC FILING Source text: (https://bit.ly/3cTYqdq) Further company coverage: